Skip to main content

Function

GFAP, a class-III intermediate filament, is a cell-specific marker that, during the development of the central nervous system, distinguishes astrocytes from other glial cells.

Involvement in disease

Alexander disease

ALXDRD

A rare disorder of the central nervous system. The most common form affects infants and young children, and is characterized by progressive failure of central myelination, usually leading to death within the first decade. Infants with Alexander disease develop a leukodystrophy with macrocephaly, seizures, and psychomotor retardation. Patients with juvenile or adult forms typically experience ataxia, bulbar signs and spasticity, and a more slowly progressive course. Histologically, Alexander disease is characterized by Rosenthal fibers, homogeneous eosinophilic inclusions in astrocytes.

None

The disease is caused by variants affecting the gene represented in this entry.

Post-translational modifications

Phosphorylated by PKN1.

Sequence similarities

Belongs to the intermediate filament family.

Tissue specificity

Expressed in cells lacking fibronectin.

Cellular localization

  • Cytoplasm
  • Associated with intermediate filaments.

Alternative names

Glial fibrillary acidic protein, GFAP

Target type

Proteins

Primary research area

Research Tools

Other research areas

  • Cardiovascular

Molecular weight

49880Da

We found 74 products in 4 categories

Search our catalogue for 'GFAP' (74)

Products

ab68428

Anti-GFAP antibody [EPR1034Y] - Astrocyte Marker

Recombinant
RabMAb
Advanced Validation
20ul selling size

ab302644

Anti-GFAP antibody [EPR1034Y] - Goat IgG (Chimeric)

Recombinant
20ul selling size

ab279291

Anti-GFAP antibody [EPR1034Y] - Rat IgG2a (Chimeric)

Recombinant
20ul selling size

ab278054

Anti-GFAP antibody [RM1003] - Astrocyte Marker

Recombinant
RabMAb
20ul selling size

ab218309

Anti-GFAP antibody [EPR1034Y] - BSA and Azide free

Recombinant
RabMAb
Advanced Validation